Additionally, the tumor microenvironment’s hypoxic conditions result in activation of hypoxia inducible factor 1α, which further upregulates TF expression in both tumor and stromal cells while promoting vascular endothelial growth factor-mediated angiogenesis, compounding endothelial dysfunction [37]. The gene discussed is VEGFA; the disease is neoplasm.